46298 Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices 

ESTIMATED ANNUALIZED BURDEN TABLE—Continued 

Data collection task Instrument/form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per response (in 

hours) 

Total response 

burden 

Usability Test .................................... 100 1 1.5 150 

Confidentiality Agreement ................ 100 1 5/60 8 

Web-based concept and prototype 

testing.

Screener ........................................... 0 1 0 0 

Web-test ........................................... 167 1 1 167 

Confidentiality Agreement ................ 167 1 5/60 14 

In person message testing ............... Screener ........................................... 200 1 10/60 33 

Message Test ................................... 50 1 1 50 

Confidentiality Agreement ................ 50 1 5/60 4 

Telephone-based message testing ... Screener ........................................... 268 1 10/60 45 

Telephone Test ................................ 67 1 1 67 

Confidentiality Agreement ................ 67 1 5/60 6 

Web-based message testing ............ Screener ........................................... 0 1 10/60 0 

Web-test ........................................... 115 1 1 115 

Confidentiality Agreement ................ 115 1 5/60 10 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,402 

Mary Oliver-Anderson, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. E8–18346 Filed 8–7–08; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation for Written Comments on 

the Development of Healthy People 

2020 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of Public Health and Science, 

Office of Disease Prevention and Health 

Promotion. 

ACTION: Notice. 

Authority: 42 U.S.C. 200u. 

SUMMARY: The Office of Disease 

Prevention and Health Promotion 

(ODPHP), Office of Public Health and 

Science (OPHS), U.S. Department of 

Health and Human Services (HHS), is 

soliciting written comments on key 

elements of Healthy People 2020, 

including the vision, mission, 

overarching goals and framework. Every 

10 years, through the Healthy People 

initiative, HHS leverages scientific 

insights and lessons from the past 

decade, along with the new knowledge 

of current data, trends, and innovations 

to develop the next iteration of national 

health promotion and disease 

prevention objectives. Healthy People 

provides science-based, 10-year national 

objectives for promoting health and 

preventing disease. Since 1979, Healthy 

People has set and monitored national 

health objectives to meet a broad range 

of health needs, encourage 

collaborations across sectors, guide 

individuals toward making informed 

health decisions, and measure the 

impact of our prevention and health 

promotion activities. Healthy People 

2020 will reflect assessments of major 

risks to health and wellness, changing 

public health priorities, and emerging 

issues related to our nation’s health 

preparedness and prevention. 

Background: The Healthy People 

process is inclusive: its strength is 

directly tied to collaboration. The 

development process strives to 

maximize transparency, public input 

and stakeholder dialogue to ensure that 

Healthy People 2020 is relevant to 

diverse public health needs and seizes 

opportunities to achieve its goals. Since 

its inception, Healthy People has 

become a broad-based, public 

engagement initiative with thousands of 

citizens helping to shape it at every step 

along the way. Drawing on the expertise 

of a Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2020 and 

public input, Healthy People will 

organize and establish a framework to 

address risk factors and determinants of 

health and the diseases and disorders 

that are affecting our communities. 

Public participation will shape 

Healthy People 2020, its purpose, goals, 

organization, and action plans. HHS has 

sought input from communities and 

stakeholders across the nation through 

six regional meetings and is soliciting 

written public comments on the 

development of Healthy People 2020 

through an online public comment 

database. As a national initiative, 

Healthy People’s success depends on a 

coordinated commitment to improve the 

health of the nation. Individuals may 

subscribe to the listserv at: http:// 

www.healthypeople.gov/Contact for the 

latest information on Healthy People 

2020 and to receive email notices of 

related Healthy People 2020. Healthy 

People 2020 will be released in twophases. The vision, mission, 

overarching goals, and organizing 

framework will be released in late 2008- 

early 2009. A year later, in January 

2010, the specific Healthy People 2020 

objectives with baselines and targets 

will be released. 

DATES: In order for comments on the 

proposed vision, mission, overarching 

goals, and framework for Healthy People 

2020 to be considered by the Secretary’s 

Advisory Committee on National Health 

Promotion and Disease Prevention 

Objectives for 2020, written comments 

must be submitted via the Internet at the 

Healthy People Web site http:// 

www.healthypeople.gov/hp2020/ 

comments by the close of business 

Eastern Daylight Time on September 2, 

2008. Comments submitted to the Web 

site after September 2, 2008 and before 

September 15, 2008 will be considered 

by HHS but not reviewed by the 

Secretary’s Advisory Committee. 

ADDRESSES: The proposed vision, 

mission, overarching goals, and 

framework for Healthy People 2020 can 

be viewed and commented on at 

http://www.healthypeople.gov/hp2020/ 

Comments. 

FOR FURTHER INFORMATION CONTACT: Email the Office of Disease Prevention 

and Health Promotion, Office of Public 

Health and Science, U.S. Department of 

Health and Human Services, at 

HP2020@hhs.gov or to Hilary Scherer at 

HP2020@norc.org (e-mail), (301) 634–

9374 (phone) or (301) 634–9301 (fax). 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices 46299 

Dated: July 24, 2008. 

Penelope Slade Royall, 

RADM, USPHS, Deputy Assistant Secretary 

for Health, (Disease Prevention and Health 

Promotion). 

[FR Doc. E8–18299 Filed 8–7–08; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Preparedness, 

Detection, and Control of Infectious 

Diseases 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting. 

Name: Clinical Laboratory Improvement 

Advisory Committee (CLIAC). 

Times and Dates: 8:30 a.m.–5 p.m., 

September 10, 2008; 8:30 a.m.–3 p.m., 

September 11, 2008. 

Place: Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., Tom 

Harkin Global Communications Center, 

Building 19, Room 232, Auditorium B, 

Atlanta, Georgia 30333. 

New Information—Online Registration 

Required: In order to expedite security 

clearance process at the CDC Roybal Campus 

located on Clifton Road, all CLIAC attendees 

are required to register in advance for the 

meeting at http://www.cdc.gov/cliac/ 

default.aspx by clicking the Register for a 

‘‘Meeting’’ link and completing all forms 

according to the instructions given. Please 

complete all the required fields and submit 

your registration as far in advance of the 

meeting date as possible. 

Note: The cut-off date for registration for 

domestic attendees is Thursday, September 

4, 2008; the cut-off date for international 

attendees to register is Monday, August 25, 

2008. 

Status: Open to the public, limited only by 

the space available. The meeting Room 

accommodates approximately 100 people. 

Purpose: This Committee is charged with 

providing scientific and technical advice and 

guidance to the Secretary of Health and 

Human Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding the 

need for, and the nature of, revisions to the 

standards under which clinical laboratories 

are regulated; the impact on medical and 

laboratory practice of proposed revisions to 

the standards; and the modification of the 

standards to accommodate technological 

advances. 

Matters to Be Discussed: The agenda will 

include updates from the CDC, the Centers 

for Medicare & Medicaid Services, and the 

Food and Drug Administration; a report from 

the CLIAC Workgroup on Good Laboratory 

Practices for Genetic Testing, and discussion 

of the Workgroup’s proposals related to such; 

presentations and discussion related to 

laboratory quality control through risk 

management; and an introduction to the 

status of waived testing and discussion of the 

potential for waiver of automated hematology 

devices. Agenda items are subject to change 

as priorities dictate. 

Providing Oral or Written Comments: It is 

the policy of CLIAC to accept written public 

comments and provide a brief period for oral 

public comments whenever possible. 

Oral Comments: In general, each 

individual or group requesting to make an 

oral presentation will be limited to a total 

time of five minutes (unless otherwise 

indicated). Speakers must also submit their 

comments in writing for inclusion in the 

meeting’s Summary Report. To assure 

adequate time is scheduled for public 

comments, individuals or groups planning to 

make an oral presentation should, when 

possible, notify the contact person below at 

least one week prior to the meeting date. 

Written Comments: For individuals or 

groups unable to attend the meeting, CLIAC 

accepts written comments until the date of 

the meeting (unless otherwise stated). 

However, the comments should be received 

at least one week prior to the meeting date 

so that the comments may be made available 

to the Committee for their consideration and 

public distribution. Written comments, one 

hard copy with original signature, should be 

provided to the contact person below. 

Written comments will be included in the 

meeting’s Summary Report. 

Contact Person for Additional Information: 

Nancy Anderson, Chief, Laboratory Practice 

Standards Branch, Division of Laboratory 

Systems, National Center for Preparedness, 

Detection, and Control of Infectious Diseases, 

Coordinating Center for Infectious Diseases, 

CDC, 1600 Clifton Road, NE., Mailstop F–11, 

Atlanta, Georgia 30333; telephone (404) 498–

2741; fax (404) 498–2219; or via e-mail at 

Nancy.Anderson@cdc.hhs.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

CDC and the Agency for Toxic Substances 

and Disease Registry. 

Dated: July 28, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E8–18285 Filed 8–7–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff; 

Modifications to the International 

Classification of Diseases, Ninth 

Revision, Clinical Modification (ICD–9–

CM), Supplementary Classification of 

External Causes of Injury and 

Poisoning 

ACTION: Notice. 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, announces 

the following modifications to the 

International Classification of Diseases, 

Ninth Revision, Clinical Modification 

(ICD–9–CM), Supplementary 

Classification of External Causes of 

Injury and Poisoning. These codes will 

become effective October 1, 2008. 

External Cause Tabular 

New code E927.0 Overexertion from 

sudden strenuous movement. Sudden 

trauma from strenuous movement 

New code E927.1 Overexertion from 

prolonged static position 

New code E927.2 Excessive physical 

exertion from prolonged activity 

New code E927.3 Cumulative trauma 

from repetitive motion 

New code E927.4 Cumulative trauma 

from repetitive impact 

New code E927.8 Other overexertion 

and strenuous and repetitive 

movements or loads 

New code E927.9 Unspecified 

overexertion and strenuous and 

repetitive movements or loads 

CONTACT PERSON FOR ADDITIONAL

INFORMATION: Donna Pickett, Medical 

Systems Specialist, Classifications and 

Public Health Data Standards Staff, 

NCHS, 3311 Toledo Road, Room 2402, 

Hyattsville, Maryland 20782, e-mail 

dfp4@cdc.gov, telephone 301–458–4434. 

The complete diagnosis addenda may be 

accessed on the NCHS Web site using 

the URL: http://www.cdc.gov/nchs/ 

datawh/ftpserv/ftpicd9/ 

ftpicd9.htm#addenda. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to modifications to 

the ICD–9–CM, for both CDC and the 


pwalker on PROD1PC71 with NOTICES